Online citations, reference lists, and bibliographies.

Gene Expression Profiling In Cervical Cancer: Identification Of Novel Markers For Disease Diagnosis And Therapy.

C. Martin, K. Astbury, Lynda McEvoy, S. O’Toole, O. Sheils, J. O'leary
Published 2009 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Cervical cancer, a potentially preventable disease, remains the second most common malignancy in women worldwide. Human papillomavirus is the single most important etiological agent in cervical cancer. HPV contributes to neoplastic progression through the action of two viral oncoproteins E6 and E7, which interfere with critical cell cycle pathways, p53, and retinoblastoma. However, evidence suggests that HPV infection alone is insufficient to induce malignant changes and other host genetic variations are important in the development of cervical cancer. Advances in molecular biology and high throughput gene expression profiling technologies have heralded a new era in biomarker discovery and identification of molecular targets related to carcinogenesis. These advancements have improved our understanding of carcinogenesis and will facilitate screening, early detection, management, and personalised targeted therapy. In this chapter, we have described the use of high density microarrays to assess gene expression profiles in cervical cancer. Using this approach we have identified a number of novel genes which are differentially expressed in cervical cancer, including several genes involved in cell cycle regulation. These include p16ink4a, MCM 3 and 5, CDC6, Geminin, Cyclins A-D, TOPO2A, CDCA1, and BIRC5. We have validated expression of mRNA using real-time PCR and protein by immunohistochemistry.
This paper references
10.1016/J.YGYNO.2006.12.032
Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
M. Manavi (2007)
10.1007/BF03256249
Gene Discovery in Cervical Cancer
C. M. Martin (2012)
10.1186/1471-2105-7-533
Effect of various normalization methods on Applied Biosystems expression array system data
Catalin C. Barbacioru (2006)
10.1158/0008-5472.CAN-07-2056
Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.
Y. Zhai (2007)
Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array.
C. Shim (1998)
10.1016/J.YGYNO.2004.08.021
Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
S. Contag (2004)
10.1016/J.BPOBGYN.2005.02.002
Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix.
W. Tjalma (2005)
10.1006/METH.2001.1262
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
K. Livak (2001)
10.1158/0008-5472.CAN-07-0260
Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates.
D. Gius (2007)
10.1016/J.CANCERGENCYTO.2004.08.007
cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study.
G. Hudelist (2005)
10.1016/J.VIROL.2004.09.045
Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
A. Santin (2005)
10.7326/0003-4819-132-10-200005160-00009
Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities
K. Nanda (2000)
10.1002/ijc.11691
Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins
S. Duensing (2004)
10.1158/1055-9965.EPI-05-0231
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
F. Bray (2005)
10.1038/modpathol.3800361
Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix
N. Murphy (2005)
10.1158/1078-0432.CCR-06-0357
Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity
B. Bachtiary (2006)
10.1038/sj.bjc.6600038
Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix
Q. Cheng (2002)
10.1586/14737159.6.2.217
Molecular profiling of cervical neoplasia
C. Martin (2006)
10.1007/S11864-004-0044-0
Adenocarcinoma of the cervix
J. Schorge (2004)
10.1002/ijc.21813
Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression
A. Chao (2006)



This paper is referenced by
Analysis of HPV16 Variants in the Carolina Women’s Care Study and a Comparison of Gene Expression Profiles of Exfoliated Cervical Cells From Women Who Either Clear or Do Not Clear an HPV16 Infection
Erica Green (2019)
10.1007/s12079-017-0376-8
Application of unique sequence index (USI) barcode to gene expression profiling in gastric adenocarcinoma
S. Fattahi (2017)
Functions of human papillomavirus E5 oncogene in epithelial cells and in the onset of cervical cancer
Niina Kivi (2011)
10.1139/bcb-2017-0063
Inhibiting polo-like kinase 1 enhances radiosensitization via modulating DNA repair proteins in non-small-cell lung cancer.
D. Yao (2018)
miR-335 inhibits cell proliferation , migration and invasion in HeLa cervical cancer cells
Lina Chen (2016)
10.1002/14651858.CD008054.pub2
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
M. Arbyn (2013)
10.1039/c4mb00084f
Deciphering global signal features of high-throughput array data from cancers.
D. Wu (2014)
10.1016/j.ab.2010.06.029
Identification of suitable reference genes for measurement of gene expression in human cervical tissues.
Y. Shen (2010)
miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression.
Ting-yi Sun (2016)
10.1007/s13277-010-0151-4
Identification of differential expressed transcripts in cervical cancer of Mexican patients
Leticia Santos (2010)
10.1016/j.csbj.2019.02.001
Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies
M. Lin (2019)
10.1007/s00216-010-4283-6
Raman chemical mapping reveals site of action of HIV protease inhibitors in HPV16 E6 expressing cervical carcinoma cells
Dong-Hyun Kim (2010)
miR-26 a inhibits the proliferation of ovarian cancer cells via regulating CDC 6 expression
Ting-yi Sun (2016)
10.1002/ijc.27699
Proteomic analysis of oropharyngeal carcinomas reveals novel HPV‐associated biological pathways
R. Slebos (2013)
10.1155/2010/423589
Protein Bioinformatics Infrastructure for the Integration and Analysis of Multiple High-Throughput “omics” Data
Chuming Chen (2010)
Cervical Cancer Prevention and Control
H. Ngan (2018)
10.1097/MD.0000000000007302
Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues
Y. Xing (2017)
10.1371/journal.pone.0111021
Quantifying mRNA and MicroRNA with qPCR in Cervical Carcinogenesis: A Validation of Reference Genes to Ensure Accurate Data
Maria da Conceição Gomes Leitão (2014)
Investigation of HIV anti-viral drug effect on HPV16 E6 expressing cervical carcinoma cells using advanced metabolomics methods
D. Kim (2011)
10.3390/diagnostics9040173
mRNA Detection in Anal Cytology: A Feasible Approach for Anal Cancer Screening in Men Who Have Sex with Men Living With HIV
Marta Del Pino (2019)
10.1155/2016/3186051
Pathogenic Network Analysis Predicts Candidate Genes for Cervical Cancer
Yun-xia Zhang (2016)
HOXC 6 expression is associated with a poor prognosis in early-stage cervical squamous cell carcinoma
Jianhong Shang (2017)
10.1007/s12254-014-0177-1
Gene signature profiling of gynaecological malignancies
Peter Horak (2014)
10.1053/j.seminoncol.2010.05.007
Molecular markers for early detection.
B. Dunn (2010)
The mode of action of the HIV protease inhibitor lopinavir against HPV
Gavin Batman (2011)
10.5301/JBM.2010.5708
Cervical cytology biobanking in Europe.
M. Arbyn (2010)
10.3892/mmr.2018.8846
Integrated analysis of long non‑coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.
W. Wu (2018)
10.2174/1874357901206010216
A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens
B. Kaczkowski (2012)
10.3346/jkms.2018.33.e303
CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer
Y. Kim (2018)
Functions of Human Papillomavirus E 5 oncogene in epithelial cells and in the onset of cervical cancer
Docent Eeva Auvinen (2011)
Feature selection and classification for high-dimensional biological data under cross-validation framework
Y. Zhong (2018)
10.1177/172460081002500301
Cervical Cytology Biobanking in Europe
M. Arbyn (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar